Akebia Therapeutics
AKBA
AKBA
156 hedge funds and large institutions have $391M invested in Akebia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 23 reducing their positions, and 19 closing their positions.
Holders
156
Holders Change
+12
Holders Change %
+8.33%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
76
Reduced
23
Closed
19
Calls
$1.97M
Puts
$1.23M
Net Calls
+$748K
Net Calls Change
+$1.28M
Top Buyers
1 |
1
BlackRock
New York
|
$66.9M |
2 |
MB
2
MPM BioImpact
Boston,
Massachusetts
|
$10.5M |
3 |
3
Morgan Stanley
New York
|
$19.4M |
4 |
NL
4
Nuveen LLC
Charlotte,
North Carolina
|
$9.86M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$53.2M |